Minocycline could improve acute ischemic stroke outcomes Giving the antibiotic minocycline to patients with acute ischemic stroke within 72 hours of symptom onset significantly improves functional outcomes at 90 days without increasing the risk for adverse…

#MedNews - Giving the antibiotic #minocycline to patients with acute ischemic #stroke within 72 hours of symptom onset significantly improves functional outcomes at 90 days without increasing the risk for adverse events.

Full story 👉 buff.ly/ISX15An

#NeuroSky

Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial Minocycline therapy initiated within 72 h of acute ischaemic stroke provided a significant functional outcome benefit compared with placebo at 90 days, without safety concerns. Future studies are need...

#Minocycline therapy initiated within 72 h of acute ischemic #stroke provided a significant functional outcome benefit compared with placebo at 90 days

#foamed #foamcc #meded #Medsky #emimcc

@pulmcrit.bsky.social has to update the chapter!

www.thelancet.com/journals/lan...

Removal of minocycline and terramycin by graphene oxide and Cr/Mn base metal–organic framework composites The graphene oxide and Cr/Mn base metal–organic framework (GO/Cr/Mn-MOF) composites were prepared by incorporating chromium acetate, tetrahydrate manganese acetate, and metal ions, using phthalic…

#GrapheneOxide and Cr/Mn base metal–organic framework (GO/Cr/Mn-MOF) composites exhibit excellent removal efficiency & high adsorption capacity for #minocycline and #Terramycin, primarily through physical adsorption.

Green Processing and Synthesis #OpenAccess:

Evidence that minocycline treatment confounds the interpretation of neurofilament as a biomarker Gentile et al. report that treatment with the drug minocycline may cause neurofilament light concentration to rise in CSF and blood. This effect appears me

#Medsky🧪 #Neurosky #pharmasky Changes in NfL are generally assumed to reflect changes in neuronal damage . #minocycline may increase #neurofilamentlight concentration in CSF and blood, potentially mediated by changes in clearance rather than release from tissue…

academic.oup.com/braincomms/a...

Minocycline-MR 40mg was recently FDA approved for rosacea. In this video, I will review the clinical trial data and share my thoughts on where it fits among our existing treatment options:
#rosacea #minocycline #emrosi
youtu.be/103ncqVznGk